Form 8.3 - [Abbvie. Inc]
January 15 2020 - 10:01AM
Dow Jones News
TIDM0QCV
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING
1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) State Street Global Advisors &
Affiliates
--------------------------------------------- -------------------------------
Company dealt in AbbVie Inc.
--------------------------------------------- -------------------------------
Class of relevant security to which US$0.01 common stock
the dealings being disclosed relate (Note 2)
--------------------------------------------- -------------------------------
Date of dealing 14(th) January 2020
--------------------------------------------- -------------------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 3)
Long Short
------------------------------------- -------------------- -----------
Number (%) Number (%)
------------------------------------- ---------- -------- ------ ---
(1) Relevant securities 69,053,180 4.66919%
------------------------------------- ---------- -------- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------- ---------- -------- ------ ---
(3) Options and agreements to
purchase/sell N/A
------------------------------------- ---------- -------- ------ ---
Total 69,053,180 4.66919%
------------------------------------- ---------- -------- ------ ---
(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3)
Class of relevant security: Long Short
------------------------------------------- ----------- -----------
Number (%) Number (%)
------------------------------------------- ------ --- ------ ---
(1) Relevant securities N/A
------------------------------------------- ------ --- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------------- ------ --- ------ ---
(3) Options and agreements to purchase/sell N/A
------------------------------------------- ------ --- ------ ---
Total N/A
------------------------------------------- ------ --- ------ ---
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit (Note 5)
-------------- ----------------------------- -----------------------
Purchase 14,800 88.20
-------------- ----------------------------- -----------------------
Purchase 5,800 88.20
-------------- ----------------------------- -----------------------
Purchase 58,100 88.20
-------------- ----------------------------- -----------------------
Purchase 6,100 88.20
-------------- ----------------------------- -----------------------
Purchase 11,233 88.20
-------------- ----------------------------- -----------------------
Purchase 16,542 88.20
-------------- ----------------------------- -----------------------
Purchase 59,679 88.20
-------------- ----------------------------- -----------------------
Purchase 2,051 88.20
-------------- ----------------------------- -----------------------
Purchase 500 88.20
-------------- ----------------------------- -----------------------
Purchase 20,580 88.20
-------------- ----------------------------- -----------------------
Purchase 1,500 88.20
-------------- ----------------------------- -----------------------
Purchase 10,110 88.20
-------------- ----------------------------- -----------------------
Purchase 14,300 88.20
-------------- ----------------------------- -----------------------
Purchase 7,932 88.20
-------------- ----------------------------- -----------------------
Purchase 696 88.20
-------------- ----------------------------- -----------------------
Purchase 960 88.20
-------------- ----------------------------- -----------------------
Purchase 4,800 88.20
-------------- ----------------------------- -----------------------
Purchase 36,114 88.20
-------------- ----------------------------- -----------------------
Purchase 135 88.20
-------------- ----------------------------- -----------------------
Purchase 3,900 88.20
-------------- ----------------------------- -----------------------
Purchase 14,743 88.20
-------------- ----------------------------- -----------------------
Purchase 352 88.20
-------------- ----------------------------- -----------------------
Purchase 1,112 88.20
-------------- ----------------------------- -----------------------
Purchase 10,019 88.20
-------------- ----------------------------- -----------------------
Sale 1,500 88.20
-------------- ----------------------------- -----------------------
Sale 58,524 88.20
-------------- ----------------------------- -----------------------
Sale 3,900 88.20
-------------- ----------------------------- -----------------------
Sale 58,100 88.20
-------------- ----------------------------- -----------------------
Sale 6,100 88.20
-------------- ----------------------------- -----------------------
Sale 14,300 88.20
-------------- ----------------------------- -----------------------
Sale 500 88.20
-------------- ----------------------------- -----------------------
Sale 4,032 87.85
-------------- ----------------------------- -----------------------
Sale 5,800 88.20
-------------- ----------------------------- -----------------------
Sale 10,335 87.85
-------------- ----------------------------- -----------------------
Sale 14,800 88.20
-------------- ----------------------------- -----------------------
Sale 8,900 88.20
-------------- ----------------------------- -----------------------
Sale 11,570 88.20
-------------- ----------------------------- -----------------------
Sale 3,966 88.20
-------------- ----------------------------- -----------------------
Sale 1,436 88.20
-------------- ----------------------------- -----------------------
Sale 566 88.20
-------------- ----------------------------- -----------------------
Sale 566 88.20
-------------- ----------------------------- -----------------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
------------- --------------------- ----------------------------- --------------
N/A
------------- --------------------- ----------------------------- --------------
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of Exercise Type, e.g. Expiry Option money
e.g. call option purchasing securities to which price American, date paid/received
varying etc. the option relates European etc. per unit (Note 5)
(Note 7)
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
N/A
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
(ii) Exercising
Product name, Number of securities Exercise price per
e.g. call option unit (Note 5)
----------------- -------------------- ------------------
N/A
----------------- -------------------- ------------------
(d) Other dealings (including transactions in respect of new securities)
(Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
--------------------- ------- -------------------------
N/A
--------------------- ------- -------------------------
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or
derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person
relating to the voting rights of any relevant securities
under any option referred to on this form or relating
to the voting rights or future acquisition or disposal
of any relevant securities to which any derivative
referred to on this form is referenced. If none, this
should be stated.
-----------------------------------------------------------
N/A
-----------------------------------------------------------
Is a Supplemental Form 8 attached? (Note 9) NO
------------------------------------------------------- -------------------
Date of disclosure 15(th) January 2020
------------------------------------------------------- -------------------
Contact name Lionel Colaco
------------------------------------------------------- -------------------
Telephone number 020 33956098
------------------------------------------------------- -------------------
If a connected EFM, name of offeree/offeror with which N/A
connected
------------------------------------------------------- -------------------
If a connected EFM, state nature of connection (Note N/A
10)
------------------------------------------------------- -------------------
(END) Dow Jones Newswires
January 15, 2020 09:46 ET (14:46 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Aug 2024 to Sep 2024
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Sep 2023 to Sep 2024